ACUTE RESPIRATORY DISTRESS SYNDROME
Clinical trials for ACUTE RESPIRATORY DISTRESS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ACUTE RESPIRATORY DISTRESS SYNDROME trials appear
Sign up with your email to follow new studies for ACUTE RESPIRATORY DISTRESS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising ARDS drug trial pulled before it began
Disease control TerminatedThis study aimed to test a drug called IC14 in people with acute respiratory distress syndrome (ARDS), a severe lung condition. Participants would have received either IC14 or a placebo for 4 days and been followed for 28 days. The trial was withdrawn before enrolling anyone, so …
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated May 17, 2026 12:56 UTC
-
New ICU pathway aims to save lives of patients with lung failure
Disease control OngoingThis study looks at whether a step-by-step care plan, called TheraPPP, helps doctors better treat patients with severe breathing failure (ARDS). The plan includes using protective ventilation, paralysis, and prone positioning. About 20,000 adults on breathing machines in Alberta …
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated May 17, 2026 12:55 UTC
-
Immune booster study for severe pneumonia pulled before start
Disease control TerminatedThis study aimed to see if adding two immune therapies—a drug called nogapendekin alfa inbakicept and special immune cells (iNKT cells)—to standard care could help critically ill adults with severe pneumonia, sepsis, or lung failure recover. It was designed for adults in the ICU …
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Stem cell infusion could be lifeline for ICU patients with lung failure
Disease control OngoingThis study tests whether a single infusion of mesenchymal stem cells (MSCs) can help treat acute respiratory distress syndrome (ARDS), a severe lung condition common in ICU patients, including those with COVID-19. About 129 adults on ventilators will first receive different doses…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Belfast Health and Social Care Trust • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
Stem cell trial for critical COVID patients withdrawn before starting
Disease control TerminatedThis study aimed to test the safety and effects of an experimental stem cell treatment (BX-U001) for adults hospitalized with severe COVID-19 pneumonia and serious breathing problems (ARDS). The trial was designed in two parts: first to find a safe dose, and then to compare that …
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Baylx Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Could carbon monoxide help heal lungs? small trial tests safety
Symptom relief OngoingThis early-phase study tests whether low doses of inhaled carbon monoxide can be safely given to adults with severe lung injury caused by sepsis or pneumonia. The main goal is to check safety and see if a personalized dosing formula works. Only 5 participants are enrolled, so res…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
COVID lung scarring: who gets it and why?
Knowledge-focused OngoingThis study looks at how often severe COVID-19 leads to lung scarring (pulmonary fibrosis) and what factors increase that risk. Researchers will follow 200 intensive care patients to see if scarring affects survival and recovery. The goal is to better understand and predict this c…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Can a blister on the arm help solve a deadly lung condition?
Knowledge-focused OngoingThis study looks at whether a drug called Racecadotril can reduce fluid leakage in skin blisters. The blisters are a safe model for what happens in the lungs of patients with Acute Respiratory Distress Syndrome (ARDS), a severe lung injury with no effective treatments. Healthy vo…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Heart scans after sepsis: a new way to protect young cancer patients
Knowledge-focused OngoingThis study looks at whether a heart MRI can be done safely in children with cancer who have recently had sepsis, a serious infection. The goal is to find hidden heart problems early so doctors can adjust treatments. About 7 participants aged 9 to 25 will be scanned within 10 days…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC
-
Global study tests emergency response to terror attacks
Knowledge-focused ENROLLING_BY_INVITATIONThis study observes how medical teams handle patients exposed to chemical, biological, radiological, nuclear, or explosive attacks. Researchers will track whether World Health Organization guidelines are followed without delay during rescue and treatment. About 1,000 patients fro…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Sponsor: St. Justine's Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC